Skip to main content
logo
Iambic Therapeutics, Inc. (IAM)
Iambic Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Iambic Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '25 Dec '24
Cash & Equivalents
207.88180.54141.58
Cash & Cash Equivalents
207.88180.54141.58
Cash Growth
-27.52%-
Receivables
11.611.320.44
Other Current Assets
3.911.731.84
Total Current Assets
223.4183.59143.87
Property, Plant & Equipment
-4.834.81
Goodwill and Intangibles
-5.025.71
Other Long-Term Assets
-1.581.36
Total Long-Term Assets
-11.4311.88
Total Assets
-195.02155.75

Liabilities

Year Ending
TTMDec '25 Dec '24
Accounts Payable
-3.322.88
Deferred Revenue
-11.316.64
Current Debt
-0.670.65
Other Current Liabilities
48.6410.996.72
Total Current Liabilities
48.6426.2916.89
Long-Term Debt
-4.795.56
Other Long-Term Liabilities
-9.172.89
Total Long-Term Liabilities
-13.968.45
Total Liabilities
-40.2525.34

Shareholders' Equity

Year Ending
TTMDec '25 Dec '24
Retained Earnings
--195.18-117.89
Comprehensive Income
-0.020.01
Shareholders' Equity
-232.56-186.56-112.25

Additional Metrics

Year Ending
TTMDec '25 Dec '24
Total Debt
5.085.466.21
Debt Growth
--12.06%-
Net Cash (Debt)
202.79175.08135.37
Net Cash (Debt) Growth
-29.33%-
Working Capital
174.77157.3126.98